Pfizer Inc
Follow13F filer, CIK 78003, New York, NY
Pfizer Inc reported $170,365,906 across 17 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 95.78% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000078003-26-000102
- Period
- 2026-06-30
- Reported value
- $170M
- Holdings
- 17
- Top 10 weight
- 95.78%
- New
- 0
- Sold out
- 1
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ORICreduced | -4,407,497 | -$42M |
| ZURAreduced | -2,300,072 | -$12.3M |
| QTTBexited | -101,618 | -$737K |
| NXTCreduced | -109,007 | -$179K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0000078003-26-000102, largest first. % of portfolio is the value over $170,365,906, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ALLOALLOGENE THERAPEUTICS INC | 22,032,040 | $46.9M | 27.55% | 0 | Timeline | ||
| CELCCELCUITY INC | 295,652 | $29.6M | 17.35% | 0 | Timeline | ||
| ARVNARVINAS INC | 3,457,815 | $27.7M | 16.24% | 0 | Timeline | ||
| PYXSPYXIS ONCOLOGY INC | 7,032,770 | $19.5M | 11.43% | 0 | Timeline | ||
| WVEWAVE LIFE SCIENCES LTD | 1,875,000 | $10.9M | 6.42% | 0 | Timeline | ||
| BHVNBIOHAVEN LTD | 505,645 | $8M | 4.7% | 0 | Timeline | ||
| CRBUCARIBOU BIOSCIENCES INC | 4,690,431 | $7.88M | 4.63% | 0 | Timeline | ||
| SPROSPERO THERAPEUTICS INC | 2,362,348 | $5.34M | 3.13% | 0 | Timeline | ||
| ZNTLZENTALIS PHARMACEUTICALS INC | 953,834 | $3.85M | 2.26% | 0 | Timeline | ||
| ORICORIC PHARMACEUTICALS INC | 372,904 | $3.55M | 2.09% | -4,407,497 | Timeline | ||
| CRDFCARDIFF ONCOLOGY INC | 2,411,575 | $3.01M | 1.77% | 0 | Timeline | ||
| ZURAZURA BIO LTD | 538,841 | $2.88M | 1.69% | -2,300,072 | Timeline | ||
| AGMBAGOMAB THERAPEUTICS NV | 75,000 | $1.04M | 0.61% | 0 | Timeline | ||
| BOLTBOLT BIOTHERAPEUTICS INC | 31,305 | $134K | 0.08% | 0 | Timeline | ||
| NXTCNEXTCURE INC | 44,347 | $73K | 0.04% | -109,007 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 2,928 | $30K | 0.02% | 0 | Timeline | ||
| SENSEONICS HLDGS INCSENSEONICS HLDGS INC | 2,171 | $12.4K | 0.01% | 0 |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| QTTBQ32 BIO INC | 101,618 | $737K | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000078003-26-000102 | base | 2026-08-13 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000078003-26-000102 | Quarter ended 2026-06-30 | 2026-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000078003-26-000064 | Quarter ended 2026-03-31 | 2026-05-12 | acceptance time not in the bulk data set |